These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17349170)

  • 1. [Adult posttransplant lymphoproliferative disease: report of 2 cases].
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1467-8. PubMed ID: 17349170
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary nonresponse to anti-cd20 therapy in gastrointestinal posttransplant lymphoproliferative disorder.
    Gökçe S; Süoğlu OD; Sökücü S; Gün F; Emiroğlu H; Celik A; Doğan O; Cevikbaş U
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):316-20. PubMed ID: 16540802
    [No Abstract]   [Full Text] [Related]  

  • 3. Posttransplant lymphoproliferative disease in a pediatric multivisceral transplant recipient.
    Martin SA
    Crit Care Nurse; 1998 Jun; 18(3):74-80. PubMed ID: 9677941
    [No Abstract]   [Full Text] [Related]  

  • 4. Posttransplant lymphoproliferative disorder and tonsillectomy in a pediatric liver transplant population.
    Nalesnik MA
    Liver Transpl; 2001 May; 7(5):466-8. PubMed ID: 11349270
    [No Abstract]   [Full Text] [Related]  

  • 5. Is hepatitis B virus reactivation a risk factor in the development of posttransplant lymphoproliferative disorder following liver transplantation?
    Luo Y; Zhang AB; Huang H; Zheng SS
    Chin Med J (Engl); 2008 Jul; 121(13):1237-40. PubMed ID: 18710646
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary central nervous system posttransplantation lymphoproliferative disorder in an elderly liver transplant recipient.
    Dahiya S; Ooi WB; Ahluwalia MS; Asik A
    J Am Geriatr Soc; 2012 Sep; 60(9):1777-8. PubMed ID: 22985151
    [No Abstract]   [Full Text] [Related]  

  • 7. High-intensity chemotherapy and rituximab for the treatment of posttransplant lymphoproliferative disorder.
    Chen RW; Sweetenham JW
    Am J Clin Oncol; 2006 Apr; 29(2):211-2. PubMed ID: 16601446
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasmacytic posttransplant lymphoproliferative disorder with hyperviscosity syndrome in a child after liver transplant.
    Yang CH; Gombar S; Twist CJ; Gratzinger D; Esquivel CO; Lau AH
    Hepatology; 2016 Dec; 64(6):2250-2252. PubMed ID: 27227484
    [No Abstract]   [Full Text] [Related]  

  • 9. Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series.
    Avolio AW; Agnes S; Barbarino R; Magalini SC; Frongillo F; Pagano L; Larocca LM; Pompili M; Caira M; Sollazzi L; Castagneto M
    Transplant Proc; 2007; 39(6):1956-60. PubMed ID: 17692665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant lymphoproliferative disease of donor origin.
    Nalesnik MA
    Arch Pathol Lab Med; 1997 Jul; 121(7):665-6. PubMed ID: 9240898
    [No Abstract]   [Full Text] [Related]  

  • 11. Monoclonal antibody therapy for posttransplant lymphoproliferative disorders.
    Habermann TM
    Liver Transpl; 2000 Sep; 6(5):657-8. PubMed ID: 10980069
    [No Abstract]   [Full Text] [Related]  

  • 12. [Post-transplant lymphoproliferative disorders: a report of two cases].
    Wang ZM; Wang LJ; Yu XR; Xu LM
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):639-40. PubMed ID: 17134580
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-transplant lymphoproliferative disorder treated with rituximab: case report.
    Meng HT; Li Y; Liu JH; Xu GX; Teng XD
    Chin Med J (Engl); 2007 May; 120(9):841-3. PubMed ID: 17531130
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transplants Artery aspergillosis after Liver Transplantation: report of 1 case].
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1469. PubMed ID: 17349171
    [No Abstract]   [Full Text] [Related]  

  • 15. Posttransplant lymphoproliferative disorder: extranodal marginal zone lymphoma occurring after renal transplantation.
    Goldfarb JM; Larson ML; Venugopal P; Gregory SA
    Clin Adv Hematol Oncol; 2006 Aug; 4(8):600-4; discussion 604-6. PubMed ID: 17099618
    [No Abstract]   [Full Text] [Related]  

  • 16. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
    Trappe R; Riess H; Babel N; Hummel M; Lehmkuhl H; Jonas S; Anagnostopoulos I; Papp-Vary M; Reinke P; Hetzer R; Dörken B; Oertel S
    Transplantation; 2007 Apr; 83(7):912-8. PubMed ID: 17460562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphoproliferative disorders after liver transplantation].
    Pageaux GP
    Gastroenterol Clin Biol; 2001 Apr; 25(4):357-66. PubMed ID: 11449124
    [No Abstract]   [Full Text] [Related]  

  • 18. Who is at risk for post-transplant lymphoproliferative disorders (PTLD) after liver transplantation?
    Aucejo F; Rofaiel G; Miller C
    J Hepatol; 2006 Jan; 44(1):19-23. PubMed ID: 16298453
    [No Abstract]   [Full Text] [Related]  

  • 19. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
    Koch DG; Christiansen L; Lazarchick J; Stuart R; Willner IR; Reuben A
    Liver Transpl; 2007 Jun; 13(6):904-12. PubMed ID: 17539010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper airway manifestations of post-transplantation lymphoproliferative disease simulating common pediatric conditions.
    Shilon Y; Tabachnik E; Poriah Y; Halperin D; Granot E
    Isr Med Assoc J; 2006 Mar; 8(3):215-6. PubMed ID: 16599062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.